ORGANOVO HOLDINGS INC (ONVO) Stock Price, Quote, News and Overview
NASDAQ:ONVO - Nasdaq - US68620A2033 - Common Stock - Currency: USD
ONVO Quote, Performance and Key Statistics
NASDAQ:ONVO (2/21/2025, 8:00:02 PM)
0.369
-0.01 (-2.61%)
The current stock price of ONVO is 0.369 USD. In the past month the price increased by 3.94%. In the past year, price decreased by -63.1%.
ONVO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ONVO
Company Profile
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 20 full-time employees. The company went IPO on 2013-08-02. The firm is focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues, as well as preclinical data. Its segments include research and development (R&D) and Mosaic Cell Sciences (Mosaic). The company is also focused on building high fidelity, 3D tissues that recapitulate key aspects of human disease. The company uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.
Company Info
ORGANOVO HOLDINGS INC
Suite 100, 11555 Sorrento Valley Road
San Diego CALIFORNIA 92075 US
CEO: Keith Murphy
Employees: 20
Company Website: https://organovo.com/
Investor Relations: http://ir.organovo.com/phoenix.zhtml?c=254194&p=irol-irhome
Phone: 18582241000
ORGANOVO HOLDINGS INC / ONVO FAQ
What is the stock price of ORGANOVO HOLDINGS INC today?
The current stock price of ONVO is 0.369 USD. The price decreased by -2.61% in the last trading session.
What is the ticker symbol for ORGANOVO HOLDINGS INC stock?
The exchange symbol of ORGANOVO HOLDINGS INC is ONVO and it is listed on the Nasdaq exchange.
On which exchange is ONVO stock listed?
ONVO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ORGANOVO HOLDINGS INC stock?
7 analysts have analysed ONVO and the average price target is 5.51 USD. This implies a price increase of 1392.68% is expected in the next year compared to the current price of 0.369. Check the ORGANOVO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ORGANOVO HOLDINGS INC worth?
ORGANOVO HOLDINGS INC (ONVO) has a market capitalization of 5.67M USD. This makes ONVO a Nano Cap stock.
How many employees does ORGANOVO HOLDINGS INC have?
ORGANOVO HOLDINGS INC (ONVO) currently has 20 employees.
What are the support and resistance levels for ORGANOVO HOLDINGS INC (ONVO) stock?
ORGANOVO HOLDINGS INC (ONVO) has a support level at 0.34 and a resistance level at 0.38. Check the full technical report for a detailed analysis of ONVO support and resistance levels.
Is ORGANOVO HOLDINGS INC (ONVO) expected to grow?
The Revenue of ORGANOVO HOLDINGS INC (ONVO) is expected to grow by 126.67% in the next year. Check the estimates tab for more information on the ONVO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ORGANOVO HOLDINGS INC (ONVO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ONVO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ONVO, evaluating the profitability, health, valuation and growth aspects
- ORGANOVO HOLDINGS INC (ONVO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ORGANOVO HOLDINGS INC (ONVO) Sales and EPS estimates to see what analysts future expectations are.
- ORGANOVO HOLDINGS INC (ONVO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ORGANOVO HOLDINGS INC (ONVO) Insider and Institutional Ownership to learn about the owners and their transactions.
- ORGANOVO HOLDINGS INC (ONVO) Stock Chart to make your own analysis
- ORGANOVO HOLDINGS INC (ONVO) Latest news and press-releases to stay up to date.
Does ORGANOVO HOLDINGS INC (ONVO) stock pay dividends?
ONVO does not pay a dividend.
What is the Price/Earnings (PE) ratio of ORGANOVO HOLDINGS INC (ONVO)?
ORGANOVO HOLDINGS INC (ONVO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
What is the Short Interest ratio of ORGANOVO HOLDINGS INC (ONVO) stock?
The outstanding short interest for ORGANOVO HOLDINGS INC (ONVO) is 0.48% of its float. Check the ownership tab for more information on the ONVO short interest.
ONVO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ONVO. When comparing the yearly performance of all stocks, ONVO is a bad performer in the overall market: 92.39% of all stocks are doing better.
ONVO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ONVO. The financial health of ONVO is average, but there are quite some concerns on its profitability.
ONVO Financial Highlights
Over the last trailing twelve months ONVO reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 50.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -185.7% | ||
| ROE | -340.82% | ||
| Debt/Equity | 0 |
ONVO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to ONVO. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 55.75% and a revenue growth 126.67% for ONVO